As mentioned by Gumy-Pause et al. 1 in correspondence to our recent study on the clinical value of genetic variants of the ataxia telangiectasia-mutated (ATM) gene in children with T-lineage acute lymphoblastic leukaemia (T-ALL), 2 we suggested that our DHPLC conditions were possibly more sensitive to detect genetic variability in ATM in comparison to the previous study by Gumy-Pause et al. 3 As it becomes clear from their correspondence, beside the reported 21 different genetic alterations in ATM in seven out of 31 T-ALL patients (23%) studied, Gumy-Pause et al. also found nine polymorphisms in 11 other patients (18/31, 58%). This new fact suggests that the frequency of carriers of ATM variants is similar in both studies (60 and 58%, respectively), indicating that the DHPLC conditions were equally sensitive to detect genetic abnormalities in ATM in both studies.
Interestingly, Gumy-Pause et al. confirm in their letter that they also found a relatively higher frequency of the intronic substitution IVS62 þ 8A/C in T-ALL patients compared to controls. Like Gumy-Pause et al., we investigated whether the IVS62 þ 8A/C alteration could trigger alternative splicing of ATM mRNA. We performed RT-PCR with primers located in exon 62 and 65 of a patient carrying this alteration. We could neither observe a difference in size of the PCR product, nor could we confirm minor splicing defects by sequencing analysis.
Remarkably, we observed a correlation between the presence of the IVS62 þ 8A/C variant and a relatively young age of the children with T-ALL (median 1.7-fold younger, Mann-Whitney U, P ¼ 0.01). We did not find this relationship for other variants, D1853N or the five coding alterations that were recently described in our study (see Table 3 of original manuscript). In the study by Liberzon et al., 4 a relation between other ATM variants and a young age was also described. This might suggest that T-ALL patients with specific ATM alterations may be susceptible to develop T-ALL in early childhood. However, the fact that the IVS62 þ 8A/C variant does not result in a different mRNA product does not support this hypothesis. In contrast to silent mutations, about 13% of T-ALL children carry five different coding alterations that may affect the biological function of ATM. As these coding alterations may be more frequently found in T-ALL cases and are linked to higher white blood cell counts and an unfavourable outcome, it is of interest to study the incidence and biological function of these five coding alterations in larger patient cohorts. In addition, it would be interesting to investigate whether genetic variability exists in other (ATM-associated) DNA repair genes and plays a role in susceptibility for T-ALL.
